Publications
Where expertise meets impact
Berry doesn’t just follow industry standards — we set them. Our team of award-winning statisticians, journal editors, and regulatory advisors leads the field in Bayesian and adaptive trial design. With research published in The New England Journal of Medicine, JAMA, and The Lancet, we’re driving innovation where it matters most.
Over 90% of our scientists published influential work this past year, advancing adaptive, Bayesian, and platform trial methodology. Our blend of academic rigor, regulatory insight, and real-world experience makes Berry a true authority in modern clinical trials.
Explore our most impactful peer-reviewed publications below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
JAMA
Infectious Disease
COVID-19
Platform
Heterogeneous Treatment Effects of Therapeutic-Dose Heparin in Patients Hospitalized for COVID-19
April 4, 2023
2023
doi: 10.1001/jama.2023.3651.
Trials Journal
Immunology and Inflammation
Platform
BEAT CF pulmonary exacerbations core protocol for evaluating the management of pulmonary exacerbations in people with cystic fibrosis
March 22, 2023
2023
DOI: 10.1186/s13063-023-07076-8
Frontiers
Neuroscience
Stroke
Early Minimally Invasive Removal of Intracerebral Hemorrhage (ENRICH): Study protocol for a multi-centered two-arm randomized adaptive trial
March 16, 2023
2023
doi: 10.3389/fneur.2023.1126958
PLOS One
Immunology and Inflammation
Platform
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints
March 9, 2023
2023
doi.org/10.1371/journal.pone.0281674
The New England Journal of Medicine
Organ Donation
Other
Hypothermia or Machine Perfusion in Kidney Donors
February 1, 2023
2023
DOI: 10.1056/NEJMoa2118265
The Lancet
Infectious Disease
COVID-19
Platform
Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial
January 28, 2023
2023
DOI: 10.1016/S0140-6736(22)02597-1
JAMA
Methodology
Stopping Rules
Conditional Power How Likely Is Trial Success?
January 23, 2023
2023
doi:10.1001/jama.2022.25080
Clinical Infectious Disease
Infectious Disease
Platform
The Staphylococcus aureus Network Adaptive Platform Trial Protocol: New Tools for an Old Foe
December 1, 2022
2022
doi.org/10.1093/cid/ciac476
No results found.
There are no results with this criteria. Try changing your search.